Key Takeaways
- • Apheon has acquired Alma, a French frozen snacks group, as part of a buy-and-build strategy targeting expansion into Benelux, Germany, and the UK markets.
- • Wolfgang de Limburg, Apheon's managing partner, outlined the acquisition strategy, signaling active deal-making in the competitive European snack sector.
- • The frozen snacks category continues to attract private equity capital, reflecting sustained investor appetite for food and beverage platforms in Europe.
- • Novo Holdings is simultaneously advancing planetary health-focused deal plans, indicating diversification within the alternative investment community.
Summary
Apheon has entered the frozen snacks market with the acquisition of Alma, a French-based snacks producer, according to an announcement from the London newsroom. The deal represents the latest private equity play in a sector that continues to draw institutional capital across Europe. Managing partner Wolfgang de Limburg outlined the firm's post-acquisition strategy, which centers on geographic expansion into Benelux, Germany, and the United Kingdom—indicating a structured buy-and-build approach designed to consolidate fragmented regional markets and achieve scale.
The frozen snacks segment has proven resilient as an investment thesis, with multiple private equity firms competing for quality platform acquisitions and bolt-on targets. The Apheon-Alma transaction reflects this sustained appetite, as sponsors seek exposure to defensive consumer staples with recurring revenue profiles. De Limburg's involvement in the transaction signals active deal sourcing and portfolio management within Apheon's investment team.
In parallel, Novo Holdings is ramping up deal activity in planetary health, a thematic area gaining traction among alternative investment managers focused on sustainability and impact-aligned returns. This dual activity—traditional food platform consolidation alongside health-focused investment—underscores the divergent strategies competing for capital in the European mid-market.
The frozen snacks segment has proven resilient as an investment thesis, with multiple private equity firms competing for quality platform acquisitions and bolt-on targets. The Apheon-Alma transaction reflects this sustained appetite, as sponsors seek exposure to defensive consumer staples with recurring revenue profiles. De Limburg's involvement in the transaction signals active deal sourcing and portfolio management within Apheon's investment team.
In parallel, Novo Holdings is ramping up deal activity in planetary health, a thematic area gaining traction among alternative investment managers focused on sustainability and impact-aligned returns. This dual activity—traditional food platform consolidation alongside health-focused investment—underscores the divergent strategies competing for capital in the European mid-market.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.